Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 7, Issue 2, Pages e2094-e2094
Publisher
Springer Nature
Online
2016-02-12
DOI
10.1038/cddis.2016.11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro
- (2015) Han Qiao et al. ACTA PHARMACOLOGICA SINICA
- The new InsP3Kinase inhibitor BIP-4 is competitive to InsP3 and blocks proliferation and adhesion of lung cancer cells
- (2015) Dominik Schröder et al. BIOCHEMICAL PHARMACOLOGY
- Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells
- (2015) Tarek M.K. Motawi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines
- (2015) Geun Hye Hwang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells
- (2015) Aik Kia Khaw et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation
- (2015) Shaoyong Lu et al. STRUCTURE
- miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
- (2015) A De Cola et al. Cell Death & Disease
- Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells
- (2015) Shu-Feng Zhou et al. Drug Design Development and Therapy
- The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis
- (2015) Lingyun Zhang et al. Oncotarget
- Everolimus and zoledronic acid--a potential synergistic treatment for lung adenocarcinoma bone metastasis
- (2014) Y. Yu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice
- (2014) Wei Yan et al. ACTA PHARMACOLOGICA SINICA
- Adenosine Triphosphate-Competitive mTOR Inhibitors: A New Class of Immunosuppressive Agents That Inhibit Allograft Rejection
- (2014) B. R. Rosborough et al. AMERICAN JOURNAL OF TRANSPLANTATION
- mTOR ATP-competitive inhibitor INK128 inhibits neuroblastoma growth via blocking mTORC signaling
- (2014) Huiyuan Zhang et al. APOPTOSIS
- Antimalarial activity of plumbagin in vitro and in animal models
- (2014) Wiriyaporn Sumsakul et al. BMC Complementary and Alternative Medicine
- Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
- (2014) Zanjing Zhai et al. BREAST CANCER RESEARCH AND TREATMENT
- Bisphosphonates in breast cancer
- (2014) Aju Mathew et al. INTERNATIONAL JOURNAL OF CANCER
- The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model
- (2014) Ke-Wang Luo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The critical role of bisphosphonates to target bone cancer metastasis: an overview
- (2014) Tejinder Singh et al. JOURNAL OF DRUG TARGETING
- Synergistic mechanism for tetrandrine on fluconazole against Candida albicans through the mitochondrial aerobic respiratory metabolism pathway
- (2014) H. Guo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Zoledronic acid in combination with alfacalcidol has additive effects on trabecular microarchitecture and mechanical properties in osteopenic ovariectomized rats
- (2014) Deepak Kumar Khajuria et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- Zoledronic acid—more than just a bone drug
- (2014) Aju Mathew et al. Nature Reviews Clinical Oncology
- Engineered nanomedicine for myeloma and bone microenvironment targeting
- (2014) A. Swami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions
- (2014) Wei Yan et al. Bone Research
- A novel in vitro system for intracellular delivery of nonviral DNA
- (2014) Haijun Tong et al. Journal of Orthopaedic Translation
- Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice — A quantitative study using microCT and Raman spectroscopy
- (2013) Xiaohong Bi et al. BONE
- Plumbagin inhibits cytokinesis inBacillus subtilisby inhibiting FtsZ assembly - a mechanistic study of its antibacterial activity
- (2013) Anusri Bhattacharya et al. FEBS Journal
- Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells
- (2013) Tingyu Wang et al. FOOD AND CHEMICAL TOXICOLOGY
- Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
- (2013) Tapasi Rana et al. PLoS One
- Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer
- (2012) Sanjay I. Thamake et al. BIOMATERIALS
- Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells
- (2012) Lavinia Insalaco et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Disorders of Bone Remodeling
- (2011) Xu Feng et al. Annual Review of Pathology-Mechanisms of Disease
- Proteus in the World of Proteins: Conformational Changes in Protein Kinases
- (2010) Matthias Rabiller et al. ARCHIV DER PHARMAZIE
- Bone resorption in syndromes of the Ras/MAPK pathway
- (2010) DA Stevenson et al. CLINICAL GENETICS
- Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK
- (2010) Estabelle Ang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes
- (2009) Rahul Checker et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Anti-Inflammatory Properties of a Novel N-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation
- (2009) H. R. Hope et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors
- (2009) Jeffrey R. Simard et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer
- (2009) I. Zinonos et al. MOLECULAR CANCER THERAPEUTICS
- NF-κB functions in osteoclasts
- (2008) N.S. Soysa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hepatitis C Virus Replicates in the Same Immune Cell Subsets in Chronic Hepatitis C and Occult Infection
- (2008) Tram N.Q. Pham et al. GASTROENTEROLOGY
- Preclinicalversusclinical drug combination studies
- (2008) Ting-Chao Chou LEUKEMIA & LYMPHOMA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now